Wells Fargo
WHWK

Wells Fargo’s Whitehawk Therapeutics WHWK Stock Holding History

Wells Fargo’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33
Closed -$59 – 7442
2025
Q1 		$59 Sell
33
-567
-95% -$1.48K ﹤0.01% 6428
2024
Q4 		$1.89K Sell
600
-2,222
-79% -$5.03K ﹤0.01% 6195
2024
Q3 		$5.81K Sell
2,822
-200
-7% -$323 ﹤0.01% 5898
2024
Q2 		$4.41K Sell
3,022
-6,769
-69% -$12.5K ﹤0.01% 5892
2024
Q1 		$22.9K Buy
9,791
+737
+8% +$1.42K ﹤0.01% 5543
2023
Q4 		$18.3K Buy
9,054
+723
+9% +$3.03K ﹤0.01% 5668
2023
Q3 		$40.3K Sell
8,331
-1,983
-19% -$11.5K ﹤0.01% 5293
2023
Q2 		$70.5K Buy
10,314
+5,592
+118% +$43.5K ﹤0.01% 5242
2023
Q1 		$34.2K Buy
4,722
+3,156
+202% +$33.7K ﹤0.01% 5376
2022
Q4 		$20.1K Sell
1,566
-158
-9% -$2.06K ﹤0.01% 5259
2022
Q3 		$25K Sell
1,724
-365
-17% -$4.8K ﹤0.01% 5297
2022
Q2 		$26K Buy
2,089
+997
+91% +$14.8K ﹤0.01% 5326
2022
Q1 		$18K Buy
1,092
+298
+38% +$5.71K ﹤0.01% 6058
2021
Q4 		$19K Buy
794
+714
+893% +$17.9K ﹤0.01% 6350
2021
Q3 		$2K Sell
80
-1
-1% -$30 ﹤0.01% 6603
2021
Q2 		$2K Hold
81
– – ﹤0.01% 6571
2021
Q1 		$1K Hold
81
– – ﹤0.01% 6783
2020
Q4 		$1K Buy
81
+33
+69% +$706 ﹤0.01% 6392
2020
Q3 		$1K Buy
48
+2
+4% +$42 ﹤0.01% 6244
2020
Q2 		$1K Buy
46
+36
+360% +$471 ﹤0.01% 6199
2020
Q1 		$0 Buy
+10
New +$92 ﹤0.01% 6941

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wells Fargo's WHWK Position: Q2 2025 in Review

Wells Fargo sold out of Whitehawk Therapeutics (WHWK) in Q2 2025, closing a stake of 33 shares — an estimated $59 sold.

Wells Fargo first reported a position in WHWK in Q1 2020 and held it in 21 quarters. The position peaked at $70.5K in Q2 2023. 39 funds tracked by Wall St. Rank hold WHWK as of Q2 2025.

  • Wells Fargo reported no remaining Whitehawk Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 33 Whitehawk Therapeutics shares in Q2 2025, an estimated $59.
  • Wells Fargo first reported a position in Whitehawk Therapeutics in Q1 2020 and held it in 21 quarters.
  • Wells Fargo's Whitehawk Therapeutics position peaked at $70.5K in Q2 2023.
  • 39 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.